GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▼ |
---|---|---|---|
7LAG | P05164 | CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-14 AKA 7-({1-[(3-phenoxyphenyl)methyl]-1H-pyrazol-4-yl}methyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine | |
7LF5 | Q6MZV7 | Structure of Hyperglycosylated Human IgG1 Fc (Fc267) | |
7LF9 | Q6MZV7 | Structure of Hyperglycosylated Human IgG1 Fc (Fc329) | |
7LQL | O67854 | Crystal structure of the R375D mutant of LeuT | |
7LRT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LRT | 7LRT | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LSA | A0A2N0UU23 | Ruminococcus bromii Amy12 with maltoheptaose | |
7LWD | P31645 | Cryo-EM structure of the wild-type human serotonin transporter complexed with vilazodone, imipramine and 15B8 Fab | |
7LWD | 7LWD | Cryo-EM structure of the wild-type human serotonin transporter complexed with vilazodone, imipramine and 15B8 Fab | |
7LWK | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation | |
7LWQ | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer | |
7LWW | P0DTC2 | Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y) | |
7M3F | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
7MEQ | O15393 | Crystal structure of human TMPRSS2 in complex with Nafamostat | |
7MG5 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-ATAT | |
7MGB | P02866 | Concanavalin A bound to a DNA glycoconjugate, A(Man-T)AT | |
7MIX | Q00975 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
7MIX | P05484 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
7MIX | P54284 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
7MIX | P54289 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
7MM0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MM0 | 7MM0 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MPG | M1E1E4 | Cryo-EM structure of Prefusion-stabilized RSV F (DS-Cav1) in complex with Fab AM14 | |
7MPG | A0A0X8XQD7 | Cryo-EM structure of Prefusion-stabilized RSV F (DS-Cav1) in complex with Fab AM14 | |
7MPG | 7MPG | Cryo-EM structure of Prefusion-stabilized RSV F (DS-Cav1) in complex with Fab AM14 | |
7MTD | P0DTC2 | Structure of aged SARS-CoV-2 S2P spike at pH 7.4 | |
7MY3 | P0DTC2 | CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike | |
7MY3 | 7MY3 | CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike | |
5V52 | Q495A1 | Structure of TIGIT bound to nectin-2 (CD112) | |
5V52 | Q92692 | Structure of TIGIT bound to nectin-2 (CD112) | |
5V56 | Q99835 | 2.9A XFEL structure of the multi-domain human smoothened receptor (with E194M mutation) in complex with TC114 | |
5V56 | P00323 | 2.9A XFEL structure of the multi-domain human smoothened receptor (with E194M mutation) in complex with TC114 | |
5V5X | Q91XX3 | Protocadherin gammaB7 EC3-6 cis-dimer structure | |
5V6F | Q9KTH2 | Crystal Structure of the Second beta-Prism Domain of RbmC from V. cholerae bound to Mannotriose | |
5V6K | Q9KTH2 | Crystal Structure of the Second beta-Prism Domain of RbmC from V. cholerae Bound to N-acetylglucosaminyl-beta-1,2-mannose | |
5V6N | Q7NDN8 | Crystal Structure of the highly open channel-stabilized mutant C27S + K33C + I9'A + N21'C of GLIC under reducing conditions. | |
5V6O | Q7NDN8 | Crystal Structure of the highly open channel-stabilized mutant G-2'I + I9'A of GLIC | |
5V6Y | P0AEY0 | Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant | |
5V6Y | Q16602 | Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant | |
5V6Y | O60894 | Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant | |
5V6Y | P35318 | Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant | |
5V7J | Q2N0S6 | Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22. | |
5V7J | 5V7J | Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22. | |
5V7N | Q92LZ4 | Crystal structure of NADPH-dependent glyoxylate/hydroxypyruvate reductase SMc04462 (SmGhrB) from Sinorhizobium meliloti in complex with NADP and 2-Keto-D-gluconic acid | |
5V8K | Q1MX24 | Homodimeric reaction center of H. modesticaldum | |
5V8K | B0TAT4 | Homodimeric reaction center of H. modesticaldum | |
5VF2 | 5VF2 | scFv 2D10 re-refined as a complex with trehalose replacing the original alpha-1,6-mannobiose | |
5VGJ | 5VGJ | Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90, bound to a scaffolded WITO V1V2 domain | |
5VGP | Q6PYX1 | Fc fragment of human IgG1 antibody, from NIST mAb | |
5VH5 | 5VH5 | Crystal Structure of Fc fragment of anti-TNFa antibody infliximab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024